B5A-31030-89169
2 vaccinations
6 coded responses
13 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 405 / KY
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — day 0, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-01
Dose 2 — Janssen/Johnson & Johnson
- 2021-04-16
-
2021-04-16
Survey response — day 14, dose 2MedDRA: Chills, Fatigue, Myalgia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Muscle aches chills fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — day 21, dose 2MedDRA: Blood pressure fluctuation, Hypertension — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Severe hypertension (165/127). Blood pressure instabilityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
-
2021-05-06
Survey response — day 35, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — day 42, dose 2MedDRA: Pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heightened overall body aches/chronic painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Emergency care, Hemianaesthesia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: I filled a VAERS report after a doctor visit for hemianesthesia after someone from v-safe contacted me. That problem advanced later and required emergency treatment and hospital admit but has since mostly resolved without treatment.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-08
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-09-30
Survey response — 6 months, dose 2MedDRA: Influenza, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flu symptoms (COVID test negative)MedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-02
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Janssen/Johnson & Johnson |
Call center
5 call center cases
3 successful · 2 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 2
Free text
Release 7 — day 14, dose 2
Symptoms: Muscle aches chills fatigue
Release 7 — day 21, dose 2
Symptoms: Severe hypertension (165/127). Blood pressure instability
Release 8 — day 35, dose 2
Symptoms: Migraine
Release 8 — day 42, dose 2
Symptoms: Heightened overall body aches/chronic pain
Release 9 — 3 months, dose 2
Symptoms: I filled a VAERS report after a doctor visit for hemianesthesia after someone from v-safe contacted me. That problem advanced later and required emergency treatment and hospital admit but has since mostly resolved without treatment.
Release 9 — 6 months, dose 2
Symptoms: Flu symptoms (COVID test negative)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood pressure fluctuation | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hemianaesthesia | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release